SPOP and neoplasm: Furthermore, wild-type SPOP suppressed HepG2 cell migration, while SPOP-M35L enhanced cell migration (Fig. 7M), together suggesting that M35L mutation likely reprograms SPOP from a tumor antagonist to a tumor promotor via substrate selection.